Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
My direct team is the best I have ever work with and my manager is one of the best in the industry
What is the best part about your compensation package?
Restricted Stock Units and 401K match
What do you like best about the leadership team?
dedication to patients with cancer
What is most positive about the culture and environment at your company?
dedication to patients with cancer
What makes you most happy at work?
new technology to treat cancer
What are some of the best things about your team?
collaborative, sense of urgency, courage to speak up, dedication to patients with cancer
Other Employee Reviews for Karyopharm Therapeutics
×